Search Results

There are 6054 results for: content related to: Development of bladder dysfunction in a rat model of dopaminergic brain lesion

  1. p-quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly

    Journal of Neuroscience Research

    Volume 79, Issue 6, 15 March 2005, Pages: 849–860, Yasuhiko Izumi, Hideyuki Sawada, Noriko Sakka, Noriyuki Yamamoto, Toshiaki Kume, Hiroshi Katsuki, Shun Shimohama and Akinori Akaike

    Article first published online : 11 FEB 2005, DOI: 10.1002/jnr.20382

  2. You have free access to this content
    Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor

    Journal of Neurochemistry

    Volume 89, Issue 3, May 2004, Pages: 776–787, Yun Min Ding, Juliann D. Jaumotte, Armando P. Signore and Michael J. Zigmond

    Article first published online : 30 MAR 2004, DOI: 10.1111/j.1471-4159.2004.02415.x

  3. 6-hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression

    Journal of Neuroscience Research

    Volume 77, Issue 5, 1 September 2004, Pages: 747–761, Qinghua Liang, Anthony K.F. Liou, Yunmin Ding, Guodong Cao, Xiao Xiao, Ruth G. Perez and Jun Chen

    Article first published online : 16 JUL 2004, DOI: 10.1002/jnr.20198

  4. You have free access to this content
    6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA

    Journal of Neurochemistry

    Volume 104, Issue 6, March 2008, Pages: 1599–1612, Maria Gomez-Lazaro, Maria F. Galindo, Caoimhín G. Concannon, Miguel F. Segura, Francisco J. Fernandez-Gomez, Nuria Llecha, Joan X. Comella, Jochen H. M. Prehn and Joaquin Jordan

    Article first published online : 7 NOV 2007, DOI: 10.1111/j.1471-4159.2007.05115.x

  5. Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells

    Journal of Neuroscience Research

    Volume 86, Issue 1, January 2008, Pages: 108–117, Eva Lin, Jane E. Cavanaugh, Rehana K. Leak, Ruth G. Perez and Michael J. Zigmond

    Article first published online : 10 SEP 2007, DOI: 10.1002/jnr.21478

  6. You have free access to this content
    Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning

    Journal of Neurochemistry

    Volume 99, Issue 4, November 2006, Pages: 1151–1163, Rehana K. Leak, Anthony K. F. Liou and Michael J. Zigmond

    Article first published online : 21 AUG 2006, DOI: 10.1111/j.1471-4159.2006.04149.x

  7. You have free access to this content
    Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death

    Journal of Neurochemistry

    Volume 96, Issue 2, January 2006, Pages: 428–443, Armando P. Signore, Zhongfang Weng, Teresa Hastings, Amber D. Van Laar, Qinghua Liang, Yong J. Lee and Jun Chen

    Article first published online : 8 DEC 2005, DOI: 10.1111/j.1471-4159.2005.03587.x

  8. You have free access to this content
    Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons

    Journal of Neurochemistry

    Volume 103, Issue 1, October 2007, Pages: 145–156, J. Rodriguez-Pallares, J. A. Parga, A. Muñoz, P. Rey, M. J. Guerra and J. L. Labandeira-Garcia

    Article first published online : 22 MAY 2007, DOI: 10.1111/j.1471-4159.2007.04699.x

  9. You have free access to this content
    Chromaffin cell death induced by 6-hydroxydopamine is independent of mitochondrial swelling and caspase activation

    Journal of Neurochemistry

    Volume 84, Issue 5, March 2003, Pages: 1066–1073, María F. Galindo, Joaquín Jordán, Carmen González-García and Valentín Ceña

    Article first published online : 18 FEB 2003, DOI: 10.1046/j.1471-4159.2003.01592.x

  10. Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6-Hydroxydopamine and Iron Chelators, Desferal and VK-28

    Annals of the New York Academy of Sciences

    Volume 1012, Issue 1, March 2004, Pages: 306–325, MOUSSA B. H. YOUDIM, GALIA STEPHENSON and DORIT BEN SHACHAR

    Article first published online : 12 JAN 2006, DOI: 10.1196/annals.1306.025

  11. You have free access to this content
    Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells

    Journal of Neurochemistry

    Volume 107, Issue 6, December 2008, Pages: 1730–1740, Yasutaka Ikeda, Shinji Tsuji, Akira Satoh, Masaharu Ishikura, Takuji Shirasawa and Takahiko Shimizu

    Article first published online : 20 OCT 2008, DOI: 10.1111/j.1471-4159.2008.05743.x

  12. Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra

    European Journal of Neuroscience

    Volume 12, Issue 8, August 2000, Pages: 3033–3043, G. Andringa, R. V. Van Oosten, W. Unger, T. G. M. Hafmans, J. Veening, J. C. Stoof and A. R. Cools

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1460-9568.2000.00181.x

  13. You have free access to this content
    Bcl-xL blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells

    Journal of Neurochemistry

    Volume 89, Issue 1, April 2004, Pages: 124–133, Joaquín Jordán, María F. Galindo, Daniel Tornero, Carmen González-García and Valentín Ceña

    Article first published online : 23 JAN 2004, DOI: 10.1046/j.1471-4159.2003.02299.x

  14. You have free access to this content
    Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease

    Journal of Neurochemistry

    Volume 77, Issue 4, May 2001, Pages: 1058–1066, Scott M. Kulich and Charleen T. Chu

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.1471-4159.2001.00304.x

  15. You have free access to this content
    Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells

    Journal of Neurochemistry

    Volume 97, Issue 1, April 2006, Pages: 234–244, Mingxing Ouyang and Xun Shen

    Article first published online : 3 MAR 2006, DOI: 10.1111/j.1471-4159.2006.03730.x

  16. You have free access to this content
    Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine

    Journal of Neurochemistry

    Volume 107, Issue 1, October 2008, Pages: 127–140, Jezabel Rodriguez-Blanco, Vanesa Martín, Federico Herrera, Guillermo García-Santos, Isaac Antolín and Carmen Rodriguez

    Article first published online : 28 JUL 2008, DOI: 10.1111/j.1471-4159.2008.05588.x

  17. You have free access to this content
    Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics

    Journal of Neurochemistry

    Volume 99, Issue 1, October 2006, Pages: 54–69, William A. Holtz, Jay M. Turetzky, Yuh-Jiin I. Jong and Karen L. O'Malley

    Article first published online : 17 JUL 2006, DOI: 10.1111/j.1471-4159.2006.04025.x

  18. Simvastatin Induces Neuroprotection in 6-OHDA-Lesioned PC12 via the PI3K/AKT/Caspase 3 Pathway and Anti-Inflammatory Responses

    CNS Neuroscience & Therapeutics

    Volume 19, Issue 3, March 2013, Pages: 170–177, Yun-Qi Xu, Ling Long, Jun-Qiang Yan, Lei Wei, Meng-Qiu Pan, Hui-Min Gao, Peng Zhou, Mei Liu, Can-Sheng Zhu, Bei-Sha Tang and Qing Wang

    Article first published online : 28 DEC 2012, DOI: 10.1111/cns.12053

  19. Subthalamic nucleus lesions induce deficits as well as benefits in the hemiparkinsonian rat

    European Journal of Neuroscience

    Volume 11, Issue 8, August 1999, Pages: 2749–2757, Jasmine M. Henderson, Lucy E. Annett, Lawrence J. Ryan, Wesley Chiang, Seiko Hidaka, Eduardo M. Torres and Stephen B. Dunnett

    Article first published online : 9 OCT 2008, DOI: 10.1046/j.1460-9568.1999.00692.x

  20. You have free access to this content
    Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

    British Journal of Pharmacology

    Volume 164, Issue 4, October 2011, Pages: 1357–1391, Susan Duty and Peter Jenner

    Article first published online : 26 SEP 2011, DOI: 10.1111/j.1476-5381.2011.01426.x